Cardinal Health Inc (CAH) : Reliance Trust Co Of Delaware scooped up 2,521 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 22,540 shares of Cardinal Health Inc which is valued at $1,696,586.Cardinal Health Inc makes up approximately 0.16% of Reliance Trust Co Of Delaware’s portfolio.
Other Hedge Funds, Including , National Pension Service boosted its stake in CAH in the latest quarter, The investment management firm added 18,775 additional shares and now holds a total of 239,029 shares of Cardinal Health Inc which is valued at $17,991,713. Cardinal Health Inc makes up approx 0.15% of National Pension Service’s portfolio.Osborn Rohs Williams Donohoe Ltd reduced its stake in CAH by selling 772 shares or 4.39% in the most recent quarter. The Hedge Fund company now holds 16,814 shares of CAH which is valued at $1,266,430. Cardinal Health Inc makes up approx 0.25% of Osborn Rohs Williams Donohoe Ltd’s portfolio.Nisa Investment Advisors reduced its stake in CAH by selling 2,310 shares or 1.54% in the most recent quarter. The Hedge Fund company now holds 147,838 shares of CAH which is valued at $11,135,158. Cardinal Health Inc makes up approx 0.15% of Nisa Investment Advisors’s portfolio.Washington Trust Bank reduced its stake in CAH by selling 235 shares or 13.49% in the most recent quarter. The Hedge Fund company now holds 1,507 shares of CAH which is valued at $114,351. Cardinal Health Inc makes up approx 0.03% of Washington Trust Bank’s portfolio.
Cardinal Health Inc closed down -0.07 points or -0.09% at $75.27 with 14,69,061 shares getting traded on Friday. Post opening the session at $75.66, the shares hit an intraday low of $75.07 and an intraday high of $75.85 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Downgraded by Goldman to ” Neutral” on Sep 16, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.